home / stock / arvn / arvn articles

ARVN Articles, Arvinas Inc. - From 02/01/24

Stock Information
Company Name: Arvinas Inc.
Stock Symbol: ARVN
Market: NASDAQ
Website: arvinas.com
Menu
ARVN ARVN Quote ARVN Short ARVN News ARVN Articles ARVN Message Board
Get ARVN Alerts

News, Short Squeeze, Breakout and More Instantly...
Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Shares of Eaton Corporation plc (NYSE: ETN) rose sharply during...
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session following weak quarterly earnings. Comtech Tele...

Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded mostly higher, with the Dow Jones index gaining more than 40 points on Friday. Shares of Torrid Holdings Inc. (NYSE: CURV) share...

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. AeroVironment posted ad...
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday. Shares of THOR Industries, Inc. (NYSE: THO) shares mo...

Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate | Benzinga

Arvinas Inc (NASDAQ: ARVN) and Pfizer Inc (NYSE: PFE) released clinical data for vepdegestrant (ARV-471) in combination with pa...

Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program | Benzinga

NEW HAVEN, Conn., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company creating a new class of ...
Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium | Benzinga

-- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib (IBRANCE&#...

Why Arvinas (ARVN) Shares Are Seeing Blue Skies | Benzinga

Arvinas Inc (NASDAQ: ARVN) shares are trading higher by 11.2% to $24.32 Monday morning after the company announced an oversubscribed $350 million p...

Arvinas Announces Oversubscribed $350 Million Private Placement | Benzinga

NEW HAVEN, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company creating a new class of...
Previous 10 Next 10